Allena Pharmaceuticals, Inc.
OTC: ALNAQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 12
- Headquarters
- Newton, United States
- IPO year
- 2017
- Market cap
- $122.0
- Website
- https://www.allenapharma.com
Loading ALNAQ…
Loading profile data…Frequently asked questions about ALNAQ
What does Allena Pharmaceuticals, Inc. (ALNAQ) do?
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designe...
Where does ALNAQ trade?
Allena Pharmaceuticals, Inc. (ALNAQ) trades on the Other OTC.
What sector is ALNAQ in?
Allena Pharmaceuticals, Inc. (ALNAQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Where is Allena Pharmaceuticals, Inc. headquartered?
Allena Pharmaceuticals, Inc. is headquartered in United States.
Does ALNAQ pay a dividend?
Allena Pharmaceuticals, Inc. (ALNAQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALNAQ go public?
Allena Pharmaceuticals, Inc. (ALNAQ) completed its initial public offering in 2017.